Ali Iranmanesh
Endocrinology, Diabetes & Metabolism · Salem, VANPI 1659303188
Payments from drug & device makers
What this record shows
That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in VA, where the typical reported total is $1,187.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 856 payments — averaging $1288.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$403K
- Novo Nordisk AS$337K
- AbbVie$176K
- Pfizer$100K
- AstraZeneca$70K
- Sanofi US Services Inc.$14K
- plus $3K from 1 others
How this compares
$0 in reported general payments places this provider in the 0th percentile of 223 endocrinology, diabetes & metabolism providers in Virginia.
See all endocrinology, diabetes & metabolism providers in Virginia →
Other endocrinology, diabetes & metabolism in Salem
- Farhad ZangenehSterling$1.2M
- James MulindaRoanoke$788K
- Jeffrey SicatGlen Allen$657K
- Dewey BaileyRoanoke$645K
- Domenica RubinoArlington$608K
- Samamtha HudsonMidlothian$372K
- Elias SirajNorfolk$316K
- Allen BurrisPowhatan$261K
- Samim EnayatFairfax$217K
- Denise ArmelliniFairfax$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.